Abametapir Completed Phase 1 Trials for Head Lice Infestation Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02061813Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
NCT02062073Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion